
John M. Cooney
Examiner (ID: 1913, Phone: (571)272-1070 , Office: P/1765 )
| Most Active Art Unit | 1765 |
| Art Unit(s) | 1641, 1711, 1503, 1207, 1796, 1765 |
| Total Applications | 2625 |
| Issued Applications | 1714 |
| Pending Applications | 193 |
| Abandoned Applications | 736 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17525763
[patent_doc_number] => 11298430
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-12
[patent_title] => Magnetic nanocomposite compositions
[patent_app_type] => utility
[patent_app_number] => 16/587973
[patent_app_country] => US
[patent_app_date] => 2019-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 27
[patent_no_of_words] => 6603
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16587973
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/587973 | Magnetic nanocomposite compositions | Sep 29, 2019 | Issued |
Array
(
[id] => 15678545
[patent_doc_number] => 20200093936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-26
[patent_title] => Therapeutic Targeting of Lipid Nanoparticles
[patent_app_type] => utility
[patent_app_number] => 16/577281
[patent_app_country] => US
[patent_app_date] => 2019-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48033
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16577281
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/577281 | Therapeutic Targeting of Lipid Nanoparticles | Sep 19, 2019 | Abandoned |
Array
(
[id] => 16459565
[patent_doc_number] => 10842893
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-24
[patent_title] => Multifunctional chelators, complexes, and compositions thereof, and methods of using same
[patent_app_type] => utility
[patent_app_number] => 16/562577
[patent_app_country] => US
[patent_app_date] => 2019-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 23
[patent_no_of_words] => 25617
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 286
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16562577
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/562577 | Multifunctional chelators, complexes, and compositions thereof, and methods of using same | Sep 5, 2019 | Issued |
Array
(
[id] => 17235618
[patent_doc_number] => 11179481
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-23
[patent_title] => Tricarbocyanine-cyclodextrin(s) conjugates and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/557162
[patent_app_country] => US
[patent_app_date] => 2019-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 7
[patent_no_of_words] => 5584
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 219
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16557162
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/557162 | Tricarbocyanine-cyclodextrin(s) conjugates and use thereof | Aug 29, 2019 | Issued |
Array
(
[id] => 15556745
[patent_doc_number] => 20200062784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => BIOREDUCIBLE N-OXIDE-BASED PROBES FOR IMAGING OF HYPOXIA
[patent_app_type] => utility
[patent_app_number] => 16/545990
[patent_app_country] => US
[patent_app_date] => 2019-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18549
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16545990
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/545990 | Bioreducible N-oxide-based probes for imaging of hypoxia | Aug 19, 2019 | Issued |
Array
(
[id] => 17066250
[patent_doc_number] => 20210268465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => PARTICLE-CONTAINING DROPLET SYSTEMS WITH MONODISPERSE FLUID VOLUMES
[patent_app_type] => utility
[patent_app_number] => 17/268954
[patent_app_country] => US
[patent_app_date] => 2019-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26076
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17268954
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/268954 | PARTICLE-CONTAINING DROPLET SYSTEMS WITH MONODISPERSE FLUID VOLUMES | Aug 15, 2019 | Abandoned |
Array
(
[id] => 16755404
[patent_doc_number] => 10973934
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-13
[patent_title] => Gadolinium bearing PCTA-based contrast agents
[patent_app_type] => utility
[patent_app_number] => 16/766619
[patent_app_country] => US
[patent_app_date] => 2019-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 13692
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16766619
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/766619 | Gadolinium bearing PCTA-based contrast agents | Aug 5, 2019 | Issued |
Array
(
[id] => 16549700
[patent_doc_number] => 10882849
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-05
[patent_title] => Dimeric contrast agents
[patent_app_type] => utility
[patent_app_number] => 16/522076
[patent_app_country] => US
[patent_app_date] => 2019-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9976
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16522076
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/522076 | Dimeric contrast agents | Jul 24, 2019 | Issued |
Array
(
[id] => 16549700
[patent_doc_number] => 10882849
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-05
[patent_title] => Dimeric contrast agents
[patent_app_type] => utility
[patent_app_number] => 16/522076
[patent_app_country] => US
[patent_app_date] => 2019-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9976
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16522076
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/522076 | Dimeric contrast agents | Jul 24, 2019 | Issued |
Array
(
[id] => 17109898
[patent_doc_number] => 20210290495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => PRE-MIXED STRONTIUM SILICATE-BASED BIOLOGICAL HYDRAULIC CEMENTING PASTE COMPOSITION, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/266102
[patent_app_country] => US
[patent_app_date] => 2019-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3264
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17266102
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/266102 | Pre-mixed strontium silicate-based biological hydraulic cementing paste composition, preparation method therefor, and application thereof | Jul 21, 2019 | Issued |
Array
(
[id] => 17193143
[patent_doc_number] => 11161884
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-02
[patent_title] => Modified biotin, streptavidin mutant, and usage of them
[patent_app_type] => utility
[patent_app_number] => 16/512894
[patent_app_country] => US
[patent_app_date] => 2019-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 21
[patent_no_of_words] => 22829
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16512894
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/512894 | Modified biotin, streptavidin mutant, and usage of them | Jul 15, 2019 | Issued |
Array
(
[id] => 17193143
[patent_doc_number] => 11161884
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-02
[patent_title] => Modified biotin, streptavidin mutant, and usage of them
[patent_app_type] => utility
[patent_app_number] => 16/512894
[patent_app_country] => US
[patent_app_date] => 2019-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 21
[patent_no_of_words] => 22829
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16512894
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/512894 | Modified biotin, streptavidin mutant, and usage of them | Jul 15, 2019 | Issued |
Array
(
[id] => 17193143
[patent_doc_number] => 11161884
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-02
[patent_title] => Modified biotin, streptavidin mutant, and usage of them
[patent_app_type] => utility
[patent_app_number] => 16/512894
[patent_app_country] => US
[patent_app_date] => 2019-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 21
[patent_no_of_words] => 22829
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16512894
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/512894 | Modified biotin, streptavidin mutant, and usage of them | Jul 15, 2019 | Issued |
Array
(
[id] => 17193143
[patent_doc_number] => 11161884
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-02
[patent_title] => Modified biotin, streptavidin mutant, and usage of them
[patent_app_type] => utility
[patent_app_number] => 16/512894
[patent_app_country] => US
[patent_app_date] => 2019-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 21
[patent_no_of_words] => 22829
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16512894
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/512894 | Modified biotin, streptavidin mutant, and usage of them | Jul 15, 2019 | Issued |
Array
(
[id] => 17023406
[patent_doc_number] => 20210247277
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => Pretreatment Method for Fluorescent Image Diagnosis
[patent_app_type] => utility
[patent_app_number] => 16/973254
[patent_app_country] => US
[patent_app_date] => 2019-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6045
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16973254
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/973254 | Pretreatment Method for Fluorescent Image Diagnosis | Jul 11, 2019 | Pending |
Array
(
[id] => 15435355
[patent_doc_number] => 20200031861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => BICONJUGATABLE LABELS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/510794
[patent_app_country] => US
[patent_app_date] => 2019-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31315
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16510794
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/510794 | Biconjugatable labels and methods of use | Jul 11, 2019 | Issued |
Array
(
[id] => 16548608
[patent_doc_number] => 10881747
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-05
[patent_title] => Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors
[patent_app_type] => utility
[patent_app_number] => 16/508826
[patent_app_country] => US
[patent_app_date] => 2019-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 58
[patent_no_of_words] => 14897
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16508826
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/508826 | Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors | Jul 10, 2019 | Issued |
Array
(
[id] => 15265207
[patent_doc_number] => 20190381337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => BORON NEUTRON CAPTURE THERAPY SYSTEM
[patent_app_type] => utility
[patent_app_number] => 16/459908
[patent_app_country] => US
[patent_app_date] => 2019-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6564
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16459908
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/459908 | BORON NEUTRON CAPTURE THERAPY SYSTEM | Jul 1, 2019 | Abandoned |
Array
(
[id] => 15020707
[patent_doc_number] => 20190321358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => ABUSE-PROOFED DOSAGE FORM
[patent_app_type] => utility
[patent_app_number] => 16/455813
[patent_app_country] => US
[patent_app_date] => 2019-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15998
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16455813
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/455813 | ABUSE-PROOFED DOSAGE FORM | Jun 27, 2019 | Abandoned |
Array
(
[id] => 17192156
[patent_doc_number] => 11160888
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-02
[patent_title] => PET tracer for imaging of neuroendocrine tumors
[patent_app_type] => utility
[patent_app_number] => 16/454631
[patent_app_country] => US
[patent_app_date] => 2019-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5035
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16454631
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/454631 | PET tracer for imaging of neuroendocrine tumors | Jun 26, 2019 | Issued |